Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023-Reference-Cited by-同舟云学术

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023

Published:2023-10-20 Issue:42 Volume:72 Page:1140-1146
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Regan Joanna J.,Moulia Danielle L.,Link-Gelles Ruth,Godfrey Monica,Mak Josephine,Najdowski Morgan,Rosenblum Hannah G.,Shah Melisa M.,Twentyman Evelyn,Meyer Sarah,Peacock Georgina,Thornburg Natalie,Havers Fiona P.,Saydah Sharon,Brooks Oliver,Talbot H. Keipp,Lee Grace M.,Bell Beth P.,Mahon Barbara E.,Daley Matthew F.,Fleming-Dutra Katherine E.,Wallace Megan

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference19 articles.

1. Fitzpatrick M, Moghadas S, Pandey A, Galvani A. Two years of U.S. COVID-19 vaccines have prevented millions of hospitalizations and deaths, to the point. New York, NY: The Commonwealth Fund; 2022. https://www.commonwealthfund.org/blog/2022/two-years-covid-vaccines-prevented-millions-deaths-hospitalizations10.26099/whsf-fp90

2. Food and Drug Administration. COVID-19 vaccines: COVID-19 vaccines authorized for emergency use or FDA-approved. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2023. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines

3. Havers F. COVID-19 epidemiology. Presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA; September 12, 2023. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-09-12/03-COVID-Havers-508.pdf

4. Saydah S. Update: epidemiologic characteristics of long COVID. Presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA; September 12, 2023. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-09-12/04-COVID-Saydah-508.pdf

5. Wallace M. Evidence to recommendations framework. Presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA; September 12, 2023. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-09-12/11-COVID-Wallace-508.pdf

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A descriptive review on the real-world impact of Moderna, inc. COVID-19 vaccines;Expert Review of Vaccines;2024-09-13

2. Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025;MMWR. Morbidity and Mortality Weekly Report;2024-09-10

3. A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children;Expert Review of Vaccines;2024-09-09

4. Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study;Frontiers in Immunology;2024-09-02

5. Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines;Vaccine;2024-09